MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease

    T. Lata (Mumbai, India)

    Objective: This study aimed to assess the effectiveness of physical activity, which includes all movements that increase energy expenditure, in conjunction with exercise, characterized as…
  • 2025 International Congress

    End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

    A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

    Objective: To describe the personal experiences and perceptions of healthcare practitioners (HCP) involved in the terminal management of people diagnosed with Parkinson's disease (PD) Background:…
  • 2025 International Congress

    Incidence and Determinants of Nodule formation in continuous subcutaneous Foslevodopa/Foscarbidopa Infusion therapy.

    S. Bray, D. Tsui, M. Georgiades, X. Chen, D. Galea, H. Morales Briceno, V. Fung (Westmead, Australia)

    Objective: This study aims to evaluate the incidence of subcutaneous (SC) nodules in Parkinson’s patients treated with continuous 24-hour SC infusion of foslevodopa/foscarbidopa (LDp/CDp) and…
  • 2025 International Congress

    Paeoniflorin Combined with Neural Stem Cell Transplantation for Parkinson’s Disease: Synergistic Effects of Cell Therapy and Inflammation Regulation

    SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

    Objective: To investigate the feasibility and efficacy of paeoniflorin (PF) combined with neural stem cell (NSC) transplantation in treating Parkinson's disease (PD). Background: Parkinson's disease…
  • 2025 International Congress

    STOP-TIC Study: Strengthening Tourette Treatment Options using TMS to Improve CBIT, a randomized sham-controlled trial

    J. Frey, J. Sherman, T. Mcgaughey, J. Suffridge, M. Khan, E. Reid, U. Najib, A. Wagle Shukla, A. Murray, M. Okun, IA. Malaty (Morgantown, USA)

    Objective: To determine if accelerated repetitive transcranial magnetic stimulation (rTMS) administered prior to Comprehensive Behavioral Intervention for Tics (CBIT) will improve tics in Tourette Syndrome…
  • 2025 International Congress

    Efficacy of Clonidine for Tourette Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials

    Y. Aljazi, A. Abunamoos, F. Alnajjar, M. Mustafa, J. Al-Tarawneh, L. Aldaher, M. Alghaniem (Amman, Jordan)

    Objective: To evaluate the efficacy of Clonidine in reducing tic severity and improving global clinical outcomes in patients with Tourette syndrome. Background: Tourette syndrome is a neurodevelopmental disorder…
  • 2025 International Congress

    The Role of the Immune System in Dystonia: Insights from HLA genotyping

    M. Lindloge, L. Scorr, B. Laabs, D. Ellinghaus, A. Franke, H. Jinnah, C. Klein, K. Lohmann (Altanta, USA)

    Objective: To characterize the association between Human Leukocyte Antigen (HLA) alleles and dystonia. Background: Dystonia is widely recognized to have great etiologic heterogeneity. A complex…
  • 2025 International Congress

    Subdomain-specific cognitive decline and its effect on caregiver burden in Mexican population living with Parkinson’s Disease.

    G. Martin-Mafud, A. Hernández-Medrano, E. Ramírez-Benitez, A. Cervantes-Arriaga, M. Rodríguez-Violante, D. Ulloa-Hernández, M. Velasco-Delgado (Mexico City, Mexico)

    Objective: To determine whether different subdomains of the MoCA associate with caregiver burden. Background: Caregivers improve the quality of life for Parkinson's patients (PwP), despite…
  • 2025 International Congress

    Longitudinal Analysis of BRAIN test in isolated REM sleep behaviour disorder with and without hyposmia.

    H. Chohan, T. Tocino, L. Pérez-Carbonell, G. Leschziner, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess motor dysfunction in individuals with polysomnography (PSG)-confirmed isolated REM Sleep Behaviour Disorder (iRBD), self-reported RBD (sRBD), and sRBD with smell loss (hyposmia).…
  • 2025 International Congress

    Clinical Characteristics and Biomarkers in Parkinson’s Disease Patients with Body-first versus Brain-first Subtypes in Parkinson’s Disease

    S. Li, Y. Tang, J. Wang (Shanghai, China)

    Objective: To investigate clinical characteristics, disease progression, potential plasma and imaging biomarkers of body-first and brain-first Parkinson’s disease (PD) subtypes. Background: PD can be classified…
  • « Previous Page
  • 1
  • …
  • 138
  • 139
  • 140
  • 141
  • 142
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley